Davis Drug Guide 17th Edition: A Comprehensive Overview
Davis Drug Guide’s 17th edition delivers crucial, current drug information for nurses, featuring red tab designations for high-alert medications and REMS icons.
The 17th edition of Davis Drug Guide remains a cornerstone resource for nursing students and professionals alike. This edition builds upon its legacy, offering comprehensive and meticulously updated drug monographs. It prioritizes patient safety with highlighted life-threatening side effects and detailed REMS information.
The guide’s continued relevance stems from its practical focus, aiding dosage calculations and providing clinical application examples. Both print and PDF versions are available, enhancing accessibility.
Key Features and Updates
Key updates in the 17th edition include enhanced coverage of high-alert medications, clearly marked with red tabs, and expanded patient safety considerations. Davis Drug Guide now features more in-depth information on drug-drug, drug-food, and drug-natural product interactions.
The guide also incorporates special considerations for geriatric (Geri) and obstetrical (OB) patient populations, ensuring tailored care recommendations.
Authors and Publication Details
The Davis Drug Guide, 17th Edition, is authored by April Hazard Vallerand, PhD, RN, FAAN, and Cynthia A. Sanoski, BS PharmD, BCPS, FCCP. It was published by F.A. Davis Company on May 21, 2020.
This edition maintains the guide’s reputation as a leading resource for comprehensive and reliable drug information for healthcare professionals.
April Hazard Vallerand and Cynthia A. Sanoski
April Hazard Vallerand holds a PhD, is a Registered Nurse (RN), and a Fellow of the American Academy of Nursing (FAAN). Cynthia A. Sanoski is a Board Certified Pharmacist (BCPS) and Fellow of the American College of Clinical Pharmacy (FCCP) with a BS PharmD.
Both authors are highly respected experts.
Publication Date and Publisher (F.A. Davis Company)
The 17th edition of Davis Drug Guide was published on May 21, 2020, by F.A. Davis Company. This well-established publisher is known for its commitment to providing high-quality educational resources for healthcare professionals, particularly within the nursing field.
It’s a trusted source.
Physical vs. Digital Formats
Davis Drug Guide, 17th Edition, is available in both print and PDF formats, catering to diverse learning preferences. The physical book remains popular, especially for clinical rotations. The PDF version offers portability and searchability, allowing quick access to drug information via “Davis PDF” searches.
Availability of Print and PDF Versions
The 17th Edition of Davis Drug Guide provides options for learning styles. A traditional print copy is readily available, while a convenient PDF replica is also offered. This digital format boasts 1488 pages and allows for easy searching and portability, enhancing accessibility for students and practitioners alike.
Accessibility and Use in Clinical Settings
Many instructors permit students to utilize the Davis Drug Guide during initial clinical rotations, recognizing its value as a point-of-care resource. The PDF version, searchable by generic drug names, proves particularly useful. Its portability and comprehensive information support safe medication administration and informed clinical decision-making.
Core Content Organization
The Davis Drug Guide organizes information within detailed drug monographs, covering essential aspects of pharmacology and clinical use. A distinctive red tab system highlights high-alert medications, promoting patient safety. Capitalized, red lettering emphasizes life-threatening side effects, ensuring quick identification of critical adverse reactions.
Drug Monographs: Structure and Information
Each drug monograph within the Davis Drug Guide presents a standardized format, including indications, contraindications, dosages, and administration routes. Detailed information on pharmacokinetics, pharmacodynamics, and adverse reactions is provided. Monographs also feature nursing considerations, patient teaching points, and relevant drug interactions for comprehensive care.
Red Tab Designations for High-Alert Medications
The Davis Drug Guide utilizes red tab designations to prominently highlight medications with a high risk of causing significant patient harm when used incorrectly. This visual cue alerts nurses to exercise extreme caution during prescribing, dispensing, and administration, enhancing patient safety and minimizing potential errors.
Patient Safety Considerations
Davis Drug Guide prioritizes patient safety through comprehensive coverage, including capitalized and highlighted life-threatening side effects for immediate recognition. The guide also features REMS (Risk Evaluation and Mitigation Strategies) icons, guiding nurses to crucial safety protocols and minimizing potential adverse events during medication administration.
Life-Threatening Side Effects (Capitalized and Highlighted)
The 17th edition of Davis Drug Guide employs a critical visual cue: life-threatening side effects are presented in RED, CAPITALIZED letters. This immediate highlighting ensures nurses quickly identify potentially fatal adverse reactions, enabling prompt intervention and safeguarding patient well-being during medication therapy and monitoring.
REMS (Risk Evaluation and Mitigation Strategies)
Davis Drug Guide 17th Edition prominently features a dedicated REMS (Risk Evaluation and Mitigation Strategies) icon. This icon alerts healthcare professionals to medications requiring specific safety protocols, ensuring adherence to FDA requirements. These strategies mitigate significant risks, enhancing patient safety through informed prescribing and monitoring practices.
Drug Interactions
Davis Drug Guide 17th Edition provides comprehensive coverage of potential drug interactions, categorized as drug-drug, drug-food, and drug-natural product interactions. This detailed information assists healthcare providers in preventing adverse events and optimizing patient outcomes by identifying and managing potential conflicts between medications;
Drug-Drug Interactions
Davis Drug Guide 17th Edition meticulously details drug-drug interactions, outlining potential effects ranging from decreased efficacy to severe, life-threatening consequences. This section empowers nurses to proactively assess patient medication lists, identify risks, and implement strategies to mitigate harmful combinations, ensuring patient safety.
Drug-Food Interactions
Davis Drug Guide 17th Edition comprehensively covers drug-food interactions, highlighting how specific foods can alter a drug’s absorption, metabolism, or excretion. Nurses can utilize this information to educate patients on dietary modifications needed while on medication, optimizing therapeutic effects and minimizing adverse reactions.
Drug-Natural Product Interactions
Davis Drug Guide 17th Edition meticulously details potential interactions between prescription medications and natural products, including herbal supplements and vitamins. This section is vital for nurses, as patients often don’t disclose natural product use, potentially leading to dangerous and unforeseen drug interactions.
Special Patient Populations
Davis Drug Guide 17th Edition provides focused guidance for administering medications to vulnerable groups. It includes dedicated “Geri” headings highlighting concerns for older adults and “OB” headings addressing obstetrical considerations. These specialized sections ensure safe and effective medication management tailored to unique patient needs.
Geriatric Considerations (Geri Heading)
Davis Drug Guide 17th Edition utilizes “Geri” headings to pinpoint specific concerns when prescribing to older adults. These sections detail age-related physiological changes impacting drug absorption, distribution, metabolism, and excretion. This focused approach promotes safer medication use and minimizes adverse effects in geriatric patients.
Obstetrical Considerations (OB Heading)
Davis Drug Guide 17th Edition incorporates “OB” headings to highlight crucial considerations for medications used during pregnancy and lactation; These sections detail potential fetal risks, effects on breastfeeding infants, and guidance for safe medication choices during these sensitive periods, ensuring optimal maternal and fetal health.
Practical Application in Nursing Practice
Davis Drug Guide 17th Edition provides nurses with essential dosage calculations and administration guidance, streamlining medication delivery. It also features clinical examples and case studies, bridging the gap between theory and practice, enabling informed decision-making at the bedside for improved patient outcomes.
Dosage Calculations and Administration Guidance
Davis Drug Guide 17th Edition expertly supports safe medication administration with clear dosage calculations and detailed guidance. It addresses specifics like heparin loading doses and methylprednisolone reconstitution, offering precise instructions for accurate drug preparation and delivery, ultimately enhancing patient safety and therapeutic effectiveness.
Clinical Examples and Case Studies
Davis Drug Guide 17th Edition bolsters clinical application through practical examples, mirroring real-world nursing scenarios. It presents cases requiring dosage calculations – like methylprednisolone IV push – and administration techniques, such as heparin loading doses, fostering critical thinking and informed decision-making at the bedside for optimal patient care.
Utilizing the Guide for Specific Drugs
Davis Drug Guide 17th Edition expertly details drug administration, offering guidance on specifics like heparin loading doses and methylprednisolone reconstitution. Users can efficiently locate information by searching generic drug names with “Davis PDF,” streamlining access to vital details for safe and effective medication management in practice.
Heparin Administration (Loading Dose)
Davis Drug Guide provides specific instructions for heparin loading dose administration, emphasizing the need for precise calculations and careful monitoring. The guide details the initial bolus dosage, followed by continuous infusion rates, ensuring nurses have the necessary information for safe and effective anticoagulation therapy initiation;
Methylprednisolone Reconstitution
Davis Drug Guide instructs to reconstitute methylprednisolone (Solu-Medrol) for IV push administration, providing precise diluent volumes. It details the correct method to ensure drug stability and accurate dosage delivery, crucial for effective anti-inflammatory treatment and minimizing potential adverse reactions in patient care settings.
Comparison to Previous Editions
Compared to the 16th edition, the Davis Drug Guide 17th edition offers updated drug information, reflecting new approvals and evolving safety guidelines. While substantial changes aren’t drastically reported, the continued focus on patient safety features and comprehensive drug monographs maintains its overall value and relevance for nursing practice.
Changes and Improvements from the 16th Edition
The 17th edition builds upon the strong foundation of the 16th, primarily updating drug information to reflect recent FDA approvals and changes in clinical practice. Improvements center around ensuring the most current details regarding dosages, interactions, and REMS programs are readily available to nurses for optimal patient care.
Overall Value and Relevance
Despite the accessibility of online resources, the Davis Drug Guide remains highly valuable, particularly for quick reference during clinicals. Its comprehensive, organized format and emphasis on patient safety—highlighting life-threatening side effects—continues to make it a relevant and trusted resource for both students and practicing nurses.
Accessing Information Beyond the Book
Many users find utilizing generic drug names alongside “Davis PDF” searches provides rapid access to essential drug information. This complements the physical book or PDF version, offering a convenient alternative. Furthermore, F.A. Davis provides supplementary online resources to enhance the guide’s utility.
Using Generic Drug Names with “Davis PDF” Searches
A highly effective method for quickly locating drug details involves searching online using the generic drug name in conjunction with “Davis PDF”. This strategy frequently yields direct access to relevant information extracted from the Davis Drug Guide, offering a convenient and efficient alternative to browsing the complete text.
Online Resources and Supplements
Beyond the printed book, supplemental online resources enhance the Davis Drug Guide experience. These digital tools provide access to updated information and potentially interactive features. While specific details vary, users can expect to find supporting materials designed to complement and extend the core content of the 17th edition.
ISBN and Edition Details
The Davis Drug Guide, 17th Edition, is readily identifiable through its unique ISBNs. The ISBN-13 is 978-1719641135, while the ISBN-10 is 171964005X. Published by F.A. Davis Company, this edition represents a significant update in pharmaceutical information, crucial for healthcare professionals needing current drug references.
ISBN-13: 978-1719641135
This ISBN-13, 978-1719641135, specifically identifies the 17th edition of the Davis Drug Guide. It’s a unique identifier used for ordering, inventory, and referencing this particular version of the comprehensive drug resource. Utilizing this number ensures you’re accessing the most current information available from F.A. Davis Company.
ISBN-10: 171964005X
The ISBN-10, 171964005X, serves as another identifier for the 17th edition of Davis Drug Guide, though ISBN-13 is now the standard. This ten-digit number is still valuable for locating the book in older catalogs or databases. Confirming either ISBN ensures you have the correct edition published by F.A. Davis Company.